GNTA Genenta Science S.p.A. American Depositary Shares
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
GNTA
—
—
Key stats
Related
About
- Industry (SIC)
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 9
- List Date
- 2021-12-15
- CIK
- 0001838716
- Homepage
- https://www.genenta.com
Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -24.99% | 12.87% | -16.89% | -22.30% | -30.04% | -16.27% |
| Feb | -- | -25.45% | 8.33% | 11.01% | 2.63% | 0.57% | -0.58% |
| Mar | -- | 12.90% | -9.45% | -16.47% | 7.01% | -31.44% | -7.49% |
| Apr | -- | -17.14% | 0.00% | -14.68% | -0.93% | 2.02% | -6.15% |
| May | -- | 34.97% | -0.89% | -2.89% | 13.35% | 41.10% | 17.13% |
| Jun | -- | -12.25% | 6.97% | -6.06% | -32.18% | 11.52% | -6.40% |
| Jul | -- | -10.17% | -7.80% | 39.47% | 0.68% | -16.76% | 1.08% |
| Aug | -- | -11.90% | 7.74% | -12.64% | -1.55% | -27.66% | -9.20% |
| Sep | -- | -4.23% | -6.53% | 8.93% | -9.83% | -30.68% | -8.47% |
| Oct | -- | -11.47% | -2.91% | 25.00% | -21.29% | -23.07% | -6.75% |
| Nov | -- | 13.30% | 3.59% | -4.59% | -21.48% | 20.62%* | 2.29% |
| Dec | -0.35% | 4.76% | -5.53% | -17.92% | -26.24% | -- | -9.06% |
| Total | -0.35% | -50.66% | 3.55% | -22.07% | -73.52% | -70.01% | -35.51% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.69
SMA 50: $0.78
SMA 200: $1.03
Current: $0.98
EMA 12: $0.72
EMA 26: $0.72
MACD: -0.0080 | Signal: 0.0372
BEARISH
ADX (14): 33.38
TREND
+DI: 38.14
−DI: 13.50
Momentum Oscillators
RSI (14): 71.83
OVERBOUGHT
Stoch %K: 67.55
Stoch %D: 42.57
Williams %R: -1.22
Volume & Volatility
BB Upper: $0.87
BB Lower: $0.51
OVERBOUGHT
OBV: 165,887,408
Vol SMA 20: 140,413
Vol ROC: 1253.93%
ATR: $0.08
True Range: $0.17
HV 20: 138.8%
HV 30: 125.9%
HV 60: 106.6%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-31T00:00:00 – 2026-11-03T00:00:00
AI Analysis
LLM Stock Analysis Report: GNTA
Executive Summary
- Overall assessment: NEUTRAL (confidence level 6/10)
- Key drivers: Technical signals indicating a potential consolidation phase, with a slight bias towards the upside
- Primary risks: Low volatility and lack of recent news catalysts
- Investment thesis: GNTA's technical momentum has stalled, but it remains within a trading range. A break above the upper Bollinger Band or a strong earnings report could spark further upside.
- Recent news sentiment impact: No recent news available, which may be contributing to the stock's lack of direction.
Technical Analysis
- Trend Direction: Short-term (1-4 weeks): Consolidation; Medium-term (1-3 months): Neutral; Long-term (3-12 months): Uptrend
- Support/Resistance Levels:
- Lower Bollinger Band: $1.55
- Middle Band: $2.16
- Upper Band: $2.77
- SMA 20: $2.16
- SMA 50: $2.82
- Momentum Signals:
- RSI (14): Neutral (41.54)
- MACD: Bearish (-0.32 / Signal: 0.00 / Histogram: -0.32)
- Bollinger Bands: Neutral (width: 56.07, signal: neutral)
News & Sentiment Analysis
- Recent Headlines Summary: No recent news available
- Sentiment Assessment: Neutral (due to lack of recent news)
- Catalyst Identification: None identified
- Market Narrative: The absence of recent news is contributing to the stock's neutral sentiment.
Risk & Volatility Assessment
- Beta Interpretation: Low risk (beta: 0.44, vs SPY)
- Volatility Regime: Low volatility (stock moves less than market)
- Options Market Signals: No options data available
- Downside Protection: Support levels and risk management considerations: $1.55 (lower Bollinger Band), SMA 20 ($2.16)
Market Context & Positioning
- Sector Performance: Neutral (relative strength vs sector/market)
- Institutional Activity: No volume patterns suggesting institutional interest
- Correlation Analysis: Low correlation with market (R-squared: 0.07)
- Relative Valuation: Trading range-bound, positioned within the middle band ($2.16)
Key Levels & Action Items
- Critical Price Levels:
- Support: $1.55 (lower Bollinger Band), SMA 20 ($2.16)
- Resistance: $2.77 (upper Bollinger Band), SMA 50 ($2.82)
- Breakout/Breakdown Levels: None identified
- Time-Sensitive Catalysts: No earnings data available, no product launches scheduled
- Risk Management: Stop-loss levels and position sizing considerations:
- Long: above $2.77 (upper Bollinger Band), below SMA 50 ($2.82)
- Short: below $1.55 (lower Bollinger Band), above SMA 20 ($2.16)
This report provides a comprehensive analysis of GNTA, highlighting its technical momentum, recent news sentiment, and risk assessment. The stock remains within a trading range, with no strong catalysts driving the price action. Investors should consider positioning themselves around key levels or waiting for potential breakout/breakdown events to emerge.
Generated
News
All GNTA news →
GNTA Options Activity & IV Rank
Loading options activity...
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.5501
Alpha: -32.31%
Correlation: 0.1543
R-Squared: 2.4%
Stock Volatility: 128.5%
Market Volatility: 12.8%
Analysis Details
Benchmark: SPY
Data Points: 247
Period: 252 trading days
Data Points: 247
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
GNTA Institutional Ownership (13F)
Filings for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
GNTA Insider Trading (Form 4)
Latest: 2026-05-05Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Pierluigi Paracchi | Chief Executive Officer | Grant (A) | +100,000 opt | — | EDGAR | |
| 2026-04-01 | Miguel Maria Mutti | Director | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-04-01 | Francesco Galimi | CMO& Head of Development | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-04-01 | Giacomoantonio Paracchi | Director | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-04-01 | Richard B Slansky | Chief Financial Officer | Grant (A) | +80,000 opt | — | EDGAR | |
| 2026-04-01 | Armon Sharei | Director | Grant (A) | +20,000 opt | — | EDGAR | |
| 2008-04-15 | Gary Siegel | Vice President, Finance | Grant (A) | +40,000 RSU | — | EDGAR | |
| 2008-04-15 | Walter Lloyd Sanders | Senior VP & COO | Other (J) | −104 | — | EDGAR | |
| 2007-09-27 | Richard J Moran | Sr. VP Chief Financial Officer | Grant (A) | +20,000 RSU | — | EDGAR | |
| 2007-08-14 | Raymond P Warrell Jr | Chairman & CEO | Buy (P) | +30,000 | $0.89 | $26.6K | EDGAR |
| 2007-08-13 | Douglas G Watson | Director | Buy (P) | +7,500 | $0.93 | $7.0K | EDGAR |
| 2007-07-12 | Christopher P Parios | Director | Grant (A) | +20,000 opt | — | EDGAR | |
| 2007-07-12 | Betsy McCaughey | Director | Grant (A) | +20,000 opt | — | EDGAR | |
| 2007-07-12 | Martin J Driscoll | Director | Grant (A) | +30,000 opt | — | EDGAR | |
| 2007-05-15 | Lorettta M Itri | Pres. & CMO | Buy (P) | +100,000 | $0.32 | $32.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
GNTA vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc | $249.0B | 27.0 | +8.2% | +41.8% | 34 |
| GILD Gilead Sciences Inc | $207.0B | — | +6.5% | +39.5% | 55 |
| MRNA Moderna, Inc. Common Stock | $101.5B | — | −27.6% | +794.4% | 52 |
| ARGX argenx SE American Depositary Shares | $58.3B | — | — | +14.8% | 55 |
| RVMD Revolution Medicines, Inc. Common Stock | $41.6B | — | — | +152.6% | 66 |
| BIIB Biogen Inc. Common Stock | $36.7B | 110.5 | +2.3% | +45.4% | 100 |
| BNTX BioNTech SE American Depositary Share | $21.7B | — | — | −8.2% | 37 |
| EXEL Exelixis Inc | $17.0B | 21.4 | +9.1% | +64.0% | 32 |
| GNTA Genenta Science S.p.A. American Deposita | $47M | — | — | −30.1% | — |
| Peer median | $49.9B | 27.0 | +6.5% | +43.6% | 53 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.